STANOVER (Stanozolol) is a dihydrotestosterone (DHT) derived anabolic androgenic steroid, or more specifically a structurally altered form. STANOVER is the DHT hormone with two structural changes that give us the Stanozolol compound. The first alteration is the introduction of an attached pyrazol group at the A-ring of the hormone replacing the 3-keto group. This modification officially classifies Stanozolol as a heterocyclic steroid. The hormone also carries an added methyl group in order to protect hormone after administration. This structural change takes place at the 17th carbon position officially classifying Stanozolol as a C17-alpha alkylated (C17-aa) anabolic steroid.